BNP Paribas Financial Markets’s iShares US Pharmaceuticals ETF IHE Stock Holding History

BNP Paribas Financial Markets’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.2M	Sell	52,491 -798	-1%	-$71.9K	﹤0.01%	2075
2026 Q1	$4.62M	Sell	53,289 -49,727	-48%	-$4.35M	﹤0.01%	2087
2025 Q4	$8.74M	Buy	103,016 +3,016	+3%	+$241K	﹤0.01%	1699
2025 Q3	$7.26M	Sell	100,000 -100,000	-50%	-$6.9M	﹤0.01%	1749
2025 Q2	$13.1M	Buy	+200,000	New	+$13M	0.01%	1269

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's IHE Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its iShares US Pharmaceuticals ETF (IHE) stake by 1.5% in Q2 2026, selling an estimated $71.9K and leaving 52,491 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

BNP Paribas Financial Markets first reported a position in IHE in Q2 2025 and has held it in 5 quarters since. The position peaked at $13.1M in Q2 2025. 201 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

BNP Paribas Financial Markets held 52,491 shares of iShares US Pharmaceuticals ETF worth $5.2M as of Q2 2026.
BNP Paribas Financial Markets sold 798 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $71.9K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2075 holding.
BNP Paribas Financial Markets first reported a position in iShares US Pharmaceuticals ETF in Q2 2025 and has held it in 5 quarters since.
BNP Paribas Financial Markets's iShares US Pharmaceuticals ETF position peaked at $13.1M in Q2 2025.
201 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.